Inke
Jorge Llorens Noguera is a seasoned business analyst and strategic manager with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as the Business Analyst Head at Inke since October 2023, Jorge evaluates healthcare market trends and develops insights to support business growth. Previous roles include Global Strategic Portfolio Manager at Synthon and Senior BD Manager for International Business at Neuraxpharm, where responsibilities encompassed out-licensing deals and business integration strategies. Jorge also held the position of Director of Pipeline & Portfolio Specialty Products at Intas Pharmaceuticals, focusing on portfolio management and opportunity analysis. Earlier career highlights include roles at Invent Farma, Qualigen, Novelty Pharma, and Ferrer, contributing to business development and alliance management. Jorge holds a Bachelor of Business Administration with a focus on Finance from the University of San Francisco.
Previous companies
This person is not in any teams
This person is not in any offices
Inke
At Inke S.A. we are dedicated to the development and manufacture of high-quality APIs, specializing in complex synthesis processes, particularly for respiratory therapies. With over 25 years of experience in micronisation and based in Barcelona, Spain, Inke has been at the forefront of pharmaceutical innovation since 1980. We are a trusted partner in the global pharmaceutical industry, supplying APIs to markets across Europe, the US, Japan, and more. Our commitment to quality and regulatory excellence is reflected in our successful inspections by major global authorities, including the US-FDA, with our most recent inspection in April 2019. Our portfolio reflects our deep commitment to innovation, patent leadership, and scientific excellence in the pharmaceutical field. We develop, patent, and implement own synthesis routes, ensuring compliance with stringent regulatory requirements and delivering tailor-made solutions for our customers. In addition to our micronisation expertise, we provide comprehensive support for the regulatory process, including Drug Master Files (DMFs), Certificates of Suitability (CEPs), and full technical assistance. Our R&D initiatives and advanced laboratory facilities make us a leading player in the respiratory therapeutics space, always pushing boundaries to meet customer and patient needs. To learn more about our expertise in inhalation therapies, please get in touch with us by sending an email to contact-inke@inke.es